Author:
Kajiwara Kengo,Nakamura Takamichi,Katsuya Hiroaki,Kakizoe Yutaka,Maekawa Ai,Kho Takehiro,Inoue Hideki,Kitamura Kenichiro,Tomita Kimio
Publisher
Japanese Society for Dialysis Therapy
Subject
Organic Chemistry,Biochemistry
Reference22 articles.
1. Leukocytapheresis Using a Leukocyte Removal Filter
2. 2) Sawada K, Ohnishi K, Fukui S, Yamada K, Yamamura M, Amano K, Amano K, Wada M, Tanida N, Satomi M, Shimoyama T : Leukosytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 30 : 322-329, 1995
3. 3) Akizawa T, Kinugasa E, Nakayama F, Kitaoka T, Koshikawa S : Clinical benefits of nafamostat mesilate as an anticoagulant for high bleeding hemodialysis. Artificial Organs 14 : 209-212, 1991
4. 4) Kanke K, Hoshino M, Tominaga K, Nakano M, Terano A, Hiraishi H : Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis. Blood Purif 25 : 370-376, 2007
5. 5) Nagase K, Fukunaga K, Ohnishi K, Kusaka T, Matoba Y, Sawada K : Detection of specific IgE antibodies to nafamostat mesilate as an indication of possible nafamostat mesilate as anticoagulant. Therapeutic Apheresis and Dialysis 8 : 45-51, 2004